A January 2024 study by the Medical University of South Carolina said,
“We looked at differences in the growth rate of the tumors before and after treatment, and we found that the tumors after treatment had a lower growth rate compared to before treatment,”
“We saw a statistically significant reduction in tumor proliferation compared to the non-treated group, so the implications are that Boswellia, this extract of frankincense, does have anti-cancer activity in humans,”
“This study was not designed to look at survival or recurrence – it was designed to see if this supplement has anti-cancer activity in humans. Since this was a positive trial, larger studies to look at endpoints of survival and recurrence are warranted,”
“This does not imply that patients should take Boswellia in place of standard breast cancer treatment.”
“What's strange about Boswellia is that it’s probably been used in medicine longer than any other plant-based product, but we still don’t have any purified active drug products from the plant,”
“It is disappointing – but based on the difficulty we had in identifying the active pharmaceutical ingredient, perhaps not surprising.”